[Burkitt's lymphoma and acute leukemias].
D000208:Acute Disease; D000818:Animals; D001215:Asparaginase / Q000627:therapeutic use; D002051:Burkitt Lymphoma / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology; D002648:Child; D003520:Cyclophosphamide / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D007938:Leukemia / Q000188:drug therapy* / Q000209:etiology / Q000235:genetics / Q000276:immunology; D008558:Melphalan / Q000627:therapeutic use; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D051379:Mice; D009858:Oncogenic Viruses; D011239:Prednisolone / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D003561:Cytarabine; D003609:Dactinomycin; D014750:Vincristine; D003520:Cyclophosphamide; D011239:Prednisolone; D015122:Mercaptopurine; D001215:Asparaginase; D008558:Melphalan; D005472:Fluorouracil; D011241:Prednisone; D008727:Methotrexate; D003630:Daunorubicin
Lymphome de Burkitt et leucémies aiguës.